— Know what they know.
Not Investment Advice
Also trades as: RMD (NYSE) · $vol 351M · RMD.AX (ASX) · $vol 40M · 0KW4.L (LSE) · $vol 0M

RSMDF Earnings

ResMed Inc.
1W: +0.0% 1M: +0.0% 3M: +35.2% YTD: -15.4% 1Y: -15.5% 3Y: +66.9% 5Y: -6.0%
$22.61
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 48 · $35.6B mcap · 964M float · 0.0000% daily turnover · Short 29% of daily vol
Credit Risk of going bust: lower than 92% of companies Debt: 2.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down 99.8%), ResMed Inc. would be worth roughly what it owes.
Total debt $825.9M against a stock market value of $35.27B.
Distance to default 15.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $459.7M (short-term plus half of long-term), stock volatility 28.8%; Altman Z 11.75. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-08-06
EPS
$0.29
▲ Beat +2.2%
Revenue
$1.5B
▲ Beat +0.2%
EPS Beat Streak: 3 quarters
Next Earnings 2026-10-29
EPS Estimate
$0.30
Range: $0.30 - $0.31
Revenue Estimate
$1.5B
1 analysts

Estimate vs Actual

Earnings Surprise History

11/19
EPS Beats
11/19
Revenue Beats
58%
EPS Beat Rate
58%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-26 quarter 2026-09-30 $0.27 $0.27 — $1,393,030,889 $1,392,910,383
2026-10-26 quarter 2026-12-30 $0.30 $0.30 — $1,451,023,806 $1,452,372,266
2026-10-26 quarter 2027-03-30 $0.31 $0.31 — $1,459,916,067 $1,461,440,542
2026-10-26 quarter 2027-06-30 $0.33 $0.33 — $1,498,884,779 $1,500,707,413
2026-10-22 annual 2029-06-30 $1.45 $1.45 — $6,582,635,093 $6,583,585,490
2026-10-22 quarter 2026-12-30 $0.30 $0.30 — $1,451,246,029 $1,451,023,806
2026-10-22 quarter 2027-06-30 $0.33 $0.33 — $1,498,940,335 $1,498,884,779
2026-10-22 quarter 2026-09-30 $0.27 $0.27 — $1,392,715,100 $1,393,030,889
2026-10-22 quarter 2027-09-30 $0.30 $0.30 — $1,462,681,029 $1,462,681,029
2026-10-22 quarter 2027-12-30 $0.33 $0.33 — $1,546,347,671 $1,546,347,671
2026-10-22 quarter 2028-06-30 $0.35 $0.35 — $1,597,104,529 $1,597,104,529
2026-10-22 annual 2027-06-30 $1.21 $1.21 — $5,812,051,885 $5,812,667,161
2026-10-22 quarter 2027-03-30 $0.31 $0.31 — $1,460,193,845 $1,459,916,067
2026-10-22 annual 2028-06-30 $1.33 $1.33 — $6,186,564,519 $6,187,155,243
2026-10-21 annual 2029-06-30 $1.45 $1.45 — $6,579,741,180 $6,582,635,093
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms